NCT01044602View on ClinicalTrials.gov

Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
ObesityType 2 Diabetes Mellitus
Interventions
OTHER

Laboratory evaluations, sleep study

Fasting plasma glucose, liver function tests, chem-7, HOMA-IR, HBA1C, lipid profile, indirect calorimetry.

OTHER

Best Medical Management

Standard of care.

PROCEDURE

Roux-en-Y gastric bypass surgery

Surgical treatment.

Trial Locations (1)

43210

The Ohio State University Medical Center, Columbus

Sponsors

Collaborators (1)

Medtronic - MITG
All Listed Sponsors
collaborator

Medtronic - MITG

INDUSTRY

lead

David Bradley MD

OTHER

NCT01044602 - Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes | Biotech Hunter | Biotech Hunter